Abstract
Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have